| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXAS | Common Stock | Award | $21.3K | +206 | +0.54% | $103.22 | 38.6K | Apr 30, 2021 | Direct | |
| transaction | EXAS | Common Stock | Sale | -$129K | -1.2K | -3.11% | $107.54 | 37.4K | Jul 29, 2021 | Direct | F1, F2 |
| transaction | EXAS | Common Stock | Sale | -$116K | -1.07K | -2.85% | $108.54 | 36.3K | Jul 29, 2021 | Direct | F1, F3 |
| transaction | EXAS | Common Stock | Sale | -$285K | -2.6K | -7.17% | $109.58 | 33.7K | Jul 29, 2021 | Direct | F1, F4 |
| transaction | EXAS | Common Stock | Sale | -$865K | -7.82K | -23.2% | $110.64 | 25.9K | Jul 29, 2021 | Direct | F1, F5 |
| transaction | EXAS | Common Stock | Sale | -$1.55M | -13.9K | -53.53% | $111.58 | 12K | Jul 29, 2021 | Direct | F1, F6 |
| transaction | EXAS | Common Stock | Sale | -$975K | -8.68K | -72.12% | $112.39 | 3.35K | Jul 29, 2021 | Direct | F1, F7 |
| transaction | EXAS | Common Stock | Sale | -$215K | -1.9K | -56.64% | $113.35 | 1.45K | Jul 29, 2021 | Direct | F1, F8 |
| transaction | EXAS | Common Stock | Sale | -$143K | -1.25K | -85.83% | $114.41 | 206 | Jul 29, 2021 | Direct | F1, F9, F10 |
| holding | EXAS | Common Stock | 1.19K | Jul 29, 2021 | Held in 401(k) Plan |
| Id | Content |
|---|---|
| F1 | The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into in November 2020. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.16 to $107.92, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.23 to $108.73, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.00 to $109.95, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.09 to $110.99, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.02 to $111.998, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.00 to $112.99, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.02 to $113.895, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.165 to $114.63, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. |
| F10 | In addition to the shares of Common Stock reported on this Form 4, which total 1,396 shares, Mr. Elliott also holds, in the aggregate, an additional 135,562 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. |
On August 2, 2021 the reporting person filed a Form 4 to report certain sales made pursuant to a Rule 10bb5-1 trading plan entered into in November 2020 (the "Trading Plan"). This Form 4/A is being filed solely to denote that the reported sales were made pursuant to the Trading Plan.